| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
KH MA MD TN |
| (30) |
Priority: |
05.07.2019 GB 201909698
09.04.2020 GB 202005327
|
| (71) |
Applicant: GlaxoSmithKline Intellectual Property (No.2)
Limited |
|
Middlesex, TW8 9GS (GB) |
|
| (72) |
Inventors: |
|
- COLLIS, Andrew John
Ulverston, Cumbria LA12 9DR (GB)
- CROWHURST, Nicola
Worthing West, Sussex BN14 8QH (GB)
- HONICKER, Katherine Joyce
Collegeville, PA 19426 (US)
- KENDREW, Steven Gary
Worthing West Sussex BN14 8QH (GB)
|
| (74) |
Representative: Kim, Young In Timothy |
|
GlaxoSmithKline
Global Patents
GSK House (CN9.25.1)
980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB) |
|
